The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 16th Jan 2013 07:16

Anglo American: Goldman Sachs reduces target price from 1650p to 1500p and reiterates its sell recommendation.Antofagasta: Goldman Sachs ups target price from 1100p to 1120p and still recommends to sell.ARM Holdings: UBS increases target price from 750p to 900p, while downgrading to neutral.Ashtead Group: Credit Suisse raises target price from 400p to 545p retaining an outperform rating.Balfour Beatty: Credit Suisse shifts target price from 275p to 279p and keeps a neutral rating.Barclays: Nomura ups target price from 230p to 270p maintaining a reduce rating.Barratt Developments: Panmure Gordon shifts target price from 211p to 220p and retains a hold recommendation.Berendsen: Credit Suisse increases target price from 640p to 710p and maintains an outperform rating.BHP Billiton: JP Morgan takes target price from 2245p to 2300p and keeps a neutral rating. Goldman Sachs ups target price from 2400p to 2450p, while its buy recommendation remains unchanged.Brammer: Jefferies raises target price from 295p to 340p and downgrades from buy to hold.BT Group: Deutsche Bank increases target price from 235p to 269p, while retaining a hold rating.Burberry Group: UBS moves target price from 1170p to 1350p and reiterates a neutral rating. Credit Suisse ups target price from 1430p to 1550p, while staying with its outperform rating. Berenberg takes price target from 1400p to 1600p keeping a buy recommendation.Capital Shopping Centres Group: JP Morgan increases target price from 380p to 400p and upgrades to neutral.Carillion: Credit Suisse ups target price from 316p to 349p and downgrades to neutral.Centrica: Barclays raises target price from 305p to 325p and keeps an underweight rating.Charlemagne Capital: JP Morgan shifts target price from 5p to 7p, while retaining an underweight rating.COLT Telecom Group: Deutsche Bank cuts target price from 155p to 145p, while its buy recommendation is reiterated.Communisis: Panmure Gordon downgrades from buy to hold with its target price still at 47p.Diageo: Nomura lowers target price from 2070p to 2040p, while the buy rating is kept. Societe Generale reduces target price from 2050p to 1900p and downgrades to hold.Eurasian Natural Resources Corporation: JP Morgan ups target price from 275p to 300p, while the neutral rating is maintained.Fenner: Investec shifts target price from 415p to 420p, while retaining a hold rating.French Connection: Seymour Pierce cuts target price from 25p to 20p still recommending to hold.Glaxo Smith Kline: Jefferies raises target price from 1450p to 1500p and reiterates a hold rating.Home Retail Group: Barclays shifts target price from 70p to 73p and retains an underweight rating.HSBC Holdings: Nomura increases target price from 660p to 730p staying with its buy recommendation.Intermediate Capital Group: Deutsche Bank ups target price from 298p to 322p and keeps a hold rating.ITV: JP Morgan moves target price from 109p to 120p and downgrades to neutral.Kazakhmys: Goldman Sachs cuts target price from 850p to 820p, while its neutral rating is reiterated.Liontrust Asset Management: JP Morgan ups target price from 112p to 134p, while keeping an underweight rating.Lonmin: After Lonmin has not been rated, Investec recommends to hold with its target price at 353p.Lloyds Banking Group: Nomura shifts target price from 37p to 42p and maintains a reduce rating.MITIE Group: Credit Suisse reduces target price from 290p to 250p and keeps an underperform rating.N Brown: Seymour Pierce moves target price from 280p to 360p reiterating its hold recommendation.Provident Financial: JP Morgan ups target price from 1626p to 1646p, while maintaining an overweight rating.Rio Tinto: UBS reduces target price from 4340p to 4320p keeping its buy recommendation. JP Morgan raises target price from 4200p to 4400p and reiterates an overweight rating. Goldman Sachs increases target price from 3400p to 3800p, while its neutral rating remains unchanged. Deutsche Bank lowers target price from 4520p to 4450p and maintains a buy recommendation. Morgan Stanley downgrades to equalweight. Rolls-Royce Group: Credit Suisse takes price target from 850p to 900p and retains a neutral rating.Royal Bank of Scotland: Nomura raises target price from 270p to 300p and stays with a reduce rating.RPS Group: Investec moves target price from 270p to 275p keeping a buy recommendation.SAB Miller: Nomura shifts target price from 2800p to 2840p maintaining a neutral rating.Signet Jewelers: UBS ups target price from 3700p to 4050p, while its buy recommendation remains unchanged.Standart Chartered: Nomura moves target price from 1600p to 1800p reiterating a buy rating.Tarsus Group: Investec takes price target from 210p to 215p, while its buy rating in unchanged.Thorntons: Investec increases target price from 30p to 45p and stays with a hold recommendation.Virgin Media: Deutsche Bank raises target price from 2325p to 3154p, while its buy recommendation is maintained.Vodafone: Deutsche Bank cuts target price from 225p to 175p and downgrades to hold.Wetherspoon JD: Investec lowers target price from 570p to 550p and retains its buy recommendation.
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.